{"id":"https://openalex.org/W4287844072","doi":"https://doi.org/10.1016/j.ygyno.2022.06.022","title":"Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study","display_name":"Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study","publication_year":2022,"publication_date":"2022-07-25","ids":{"openalex":"https://openalex.org/W4287844072","doi":"https://doi.org/10.1016/j.ygyno.2022.06.022","pmid":"https://pubmed.ncbi.nlm.nih.gov/35902297"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2022.06.022","doi":"https://doi.org/10.1016/j.ygyno.2022.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.ygyno.2022.06.022","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042461515","display_name":"Florence Joly","orcid":"https://orcid.org/0000-0001-7004-9895","observed_orcids":["https://orcid.org/0000-0001-7004-9895","https://orcid.org/0000-0001-6168-4942","https://orcid.org/0000-0001-8018-6359"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]},{"id":"https://openalex.org/I98702875","display_name":"Universit\u00e9 de Caen Normandie","ror":"https://ror.org/051kpcy16","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Florence Joly","raw_affiliation_strings":["Medical Oncology Department, Centre Fran\u00e7ois Baclesse, Anticipe Inserm U1086, Universit\u00e9 Caen Normandie, Caen, France. Electronic address: f.joly@baclesse.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, Anticipe Inserm U1086, Universit\u00e9 Caen Normandie, Caen, France. Electronic address: f.joly@baclesse.unicancer.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210121964","https://openalex.org/I98702875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086083902","display_name":"Michel Fabbro","orcid":"https://orcid.org/0000-0003-1910-4777","observed_orcids":["https://orcid.org/0000-0003-1910-4777"]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Michel Fabbro","raw_affiliation_strings":["Medical Oncology Department, Institut R\u00e9gional du Cancer de Montpellier (ICM), Montpellier, France. Electronic address: Michel.Fabbro@icm.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institut R\u00e9gional du Cancer de Montpellier (ICM), Montpellier, France. Electronic address: Michel.Fabbro@icm.unicancer.fr","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034544552","display_name":"Dominique Berton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106090","display_name":"Institut de Canc\u00e9rologie de l'Ouest","ror":"https://ror.org/01m6as704","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210106090"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Dominique Berton","raw_affiliation_strings":["Medical Oncology Department, Institut de Canc\u00e9rologie de l'Ouest, Saint Herblain, France. Electronic address: dominique.berton@ico.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institut de Canc\u00e9rologie de l'Ouest, Saint Herblain, France. Electronic address: dominique.berton@ico.unicancer.fr","institution_ids":["https://openalex.org/I4210106090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031850292","display_name":"Justine Lequesne","orcid":"https://orcid.org/0000-0001-7046-1003","observed_orcids":["https://orcid.org/0000-0001-7046-1003"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Justine Lequesne","raw_affiliation_strings":["Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France. Electronic address: j.lequesne@baclesse.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Department, Centre Fran\u00e7ois Baclesse, Caen, France. Electronic address: j.lequesne@baclesse.unicancer.fr","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012447228","display_name":"Am\u00e9lie Anota","orcid":"https://orcid.org/0000-0001-6896-1367","observed_orcids":["https://orcid.org/0000-0001-6896-1367"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Am\u00e9lie Anota","raw_affiliation_strings":["Biostatistics Unit, Direction of Clinical Research and Innovation, Social and Human Sciences Department, and French National Platform Quality of Life and Cancer, Centre L\u00e9on B\u00e9rard, Lyon, France. Electronic address: Amelie.ANOTA@lyon.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Unit, Direction of Clinical Research and Innovation, Social and Human Sciences Department, and French National Platform Quality of Life and Cancer, Centre L\u00e9on B\u00e9rard, Lyon, France. Electronic address: Amelie.ANOTA@lyon.unicancer.fr","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040855511","display_name":"Alicja Puszkiel","orcid":"https://orcid.org/0000-0003-2954-4418","observed_orcids":["https://orcid.org/0000-0003-2954-4418"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Alicja Puszkiel","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France. Electronic address: alicjapuszkiel@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France. Electronic address: alicjapuszkiel@gmail.com","institution_ids":["https://openalex.org/I100532134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091655083","display_name":"Anne Floquet","orcid":"https://orcid.org/0000-0002-1078-8554","observed_orcids":["https://orcid.org/0000-0002-1078-8554"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Anne Floquet","raw_affiliation_strings":["Medical Oncology Department, Institute Bergoni\u00e9, Bordeaux, France. Electronic address: a.floquet@bordeaux.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institute Bergoni\u00e9, Bordeaux, France. Electronic address: a.floquet@bordeaux.unicancer.fr","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091793463","display_name":"H\u00e9l\u00e8ne Vegas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"H\u00e9l\u00e8ne Vegas","raw_affiliation_strings":["Medical Oncology Department, CHU Bretonneau Centre, Tours University, Tours, France. Electronic address: h.vegas@chu-tours.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, CHU Bretonneau Centre, Tours University, Tours, France. Electronic address: h.vegas@chu-tours.fr","institution_ids":["https://openalex.org/I110017253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021197091","display_name":"Hugues Pierre Bourgeois","orcid":"https://orcid.org/0000-0001-6682-4916","observed_orcids":["https://orcid.org/0000-0001-6682-4916","https://orcid.org/0009-0006-2720-9172"]},"institutions":[{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]},{"id":"https://openalex.org/I4210135187","display_name":"Clinique Victor Hugo","ror":"https://ror.org/04qvenw96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210135187"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Hugues Bourgeois","raw_affiliation_strings":["Medical Oncology Department, Centre Jean Bernard - Clinique Victor Hugo, Le Mans, France. Electronic address: h.bourgeois@ilcgroupe.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Jean Bernard - Clinique Victor Hugo, Le Mans, France. Electronic address: h.bourgeois@ilcgroupe.fr","institution_ids":["https://openalex.org/I4210123491","https://openalex.org/I4210135187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086294065","display_name":"Le\u00efla Bengrine-Lef\u00e8vre","orcid":"https://orcid.org/0000-0002-0762-7303","observed_orcids":["https://orcid.org/0000-0002-0762-7303"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Le\u00efla Bengrine Lefevre","raw_affiliation_strings":["Medical Oncology Department, Centre Georges Fran\u00e7ois Leclerc, Dijon, France. Electronic address: lbengrine@cgfl.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Georges Fran\u00e7ois Leclerc, Dijon, France. Electronic address: lbengrine@cgfl.fr","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073787373","display_name":"Beno\u00eet You","orcid":"https://orcid.org/0000-0002-3177-8857","observed_orcids":["https://orcid.org/0000-0002-3177-8857"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I203339264","display_name":"Universit\u00e9 de Lyon","ror":"https://ror.org/01rk35k63","country_code":"FR","type":"education","lineage":["https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Beno\u00eet You","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France; Medical Oncology Department, Institut de Canc\u00e9rologie des Hospices Civils de Lyon (IC-HCL), Centre d'Investigation de Th\u00e9rapeutiques en Oncologie et H\u00e9matologie de Lyon (CITOHL), Lyon, France. Electronic address: benoit.you@chu-lyon.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France; Medical Oncology Department, Institut de Canc\u00e9rologie des Hospices Civils de Lyon (IC-HCL), Centre d'Investigation de Th\u00e9rapeutiques en Oncologie et H\u00e9matologie de Lyon (CITOHL), Lyon, France. Electronic address: benoit.you@chu-lyon.fr","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I203339264","https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079807284","display_name":"Fanny Pommeret","orcid":"https://orcid.org/0000-0001-5584-0224","observed_orcids":["https://orcid.org/0000-0001-5584-0224"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fanny Pommeret","raw_affiliation_strings":["D\u00e9partement de M\u00e9decine Oncologique, Gustave Roussy, Villejuif, France. Electronic address: fanny.pommeret@gustaveroussy.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de M\u00e9decine Oncologique, Gustave Roussy, Villejuif, France. Electronic address: fanny.pommeret@gustaveroussy.fr","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072225627","display_name":"Alain H. Lortholary","orcid":"https://orcid.org/0000-0002-2585-6193","observed_orcids":["https://orcid.org/0000-0002-2585-6193"]},"institutions":[{"id":"https://openalex.org/I4210135503","display_name":"H\u00f4pital priv\u00e9 du Confluent","ror":"https://ror.org/043x6pn39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210135503"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Alain Lortholary","raw_affiliation_strings":["Oncology Department, Centre Catherine de Sienne, H\u00f4pital Priv\u00e9 du Confluent, Nantes, France. Electronic address: alain.lortholary@groupeconfluent.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Centre Catherine de Sienne, H\u00f4pital Priv\u00e9 du Confluent, Nantes, France. Electronic address: alain.lortholary@groupeconfluent.fr","institution_ids":["https://openalex.org/I4210135503"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108249703","display_name":"Dominique Spa\u00ebth","orcid":"https://orcid.org/0009-0004-3161-511X","observed_orcids":["https://orcid.org/0009-0004-3161-511X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dominique Spaeth","raw_affiliation_strings":["Oncology Department, Centre d'Oncologie de Gentilly, Nancy, France. Electronic address: d.spaeth@ilcgroupe.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Centre d'Oncologie de Gentilly, Nancy, France. Electronic address: d.spaeth@ilcgroupe.fr","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021893779","display_name":"Anne Claire Hardy Bessard","orcid":"https://orcid.org/0000-0001-5388-4362","observed_orcids":["https://orcid.org/0000-0001-5388-4362"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Anne-Claire Hardy-Bessard","raw_affiliation_strings":["Medical Oncology Department, Centre Armoricain de Radioth\u00e9rapie, d'Imagerie M\u00e9dicale et d'Oncologie (CARIO)-H\u00f4pital Priv\u00e9 des C\u00f4tes D'Armor (HPCA), Pl\u00e9rin, France. Electronic address: ac.hardy@cario-sante.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Armoricain de Radioth\u00e9rapie, d'Imagerie M\u00e9dicale et d'Oncologie (CARIO)-H\u00f4pital Priv\u00e9 des C\u00f4tes D'Armor (HPCA), Pl\u00e9rin, France. Electronic address: ac.hardy@cario-sante.fr","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040102390","display_name":"Cyril Abdeddaim","orcid":"https://orcid.org/0000-0002-3856-6785","observed_orcids":["https://orcid.org/0000-0002-3856-6785"]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Cyril Abdeddaim","raw_affiliation_strings":["Medical Oncology Department, Centre Oscar Lambret, Lille, France. Electronic address: c-abdeddaim@o-lambret.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Oscar Lambret, Lille, France. Electronic address: c-abdeddaim@o-lambret.fr","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057110201","display_name":"Marie\u2010Christine Kaminsky","orcid":"https://orcid.org/0000-0002-0597-5160","observed_orcids":["https://orcid.org/0000-0002-0597-5160"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Marie-Christine Kaminsky-Forrett","raw_affiliation_strings":["Medical Oncology Department, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre Les Nancy, France. Electronic address: mc.kaminsky@nancy.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre Les Nancy, France. Electronic address: mc.kaminsky@nancy.unicancer.fr","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049641705","display_name":"Michel M. Tod","orcid":"https://orcid.org/0000-0002-4632-5586","observed_orcids":["https://orcid.org/0000-0002-4632-5586"]},"institutions":[{"id":"https://openalex.org/I4210089315","display_name":"H\u00f4pital de la Croix-Rousse","ror":"https://ror.org/006evg656","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210089315","https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210135640","display_name":"Laboratoire de Biom\u00e9trie et Biologie Evolutive","ror":"https://ror.org/03skt0t88","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I1326498283","https://openalex.org/I203339264","https://openalex.org/I4210100596","https://openalex.org/I4210104684","https://openalex.org/I4210107625","https://openalex.org/I4210135640"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Michel Tod","raw_affiliation_strings":["Pharmacie, H\u00f4pital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France. Electronic address: michel.tod@chu-lyon.fr","LBBE - Laboratoire de Biom\u00e9trie et Biologie Evolutive - UMR 5558 (43 Bld du 11 Novembre 1918 69622 VILLEURBANNE CEDEX - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie, H\u00f4pital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France. Electronic address: michel.tod@chu-lyon.fr","institution_ids":["https://openalex.org/I4210089315","https://openalex.org/I4210100596"]},{"raw_affiliation_string":"LBBE - Laboratoire de Biom\u00e9trie et Biologie Evolutive - UMR 5558 (43 Bld du 11 Novembre 1918 69622 VILLEURBANNE CEDEX - France)","institution_ids":["https://openalex.org/I4210135640"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084177861","display_name":"Jean\u2010Emmanuel Kurtz","orcid":"https://orcid.org/0000-0003-4611-5797","observed_orcids":["https://orcid.org/0000-0003-4611-5797"]},"institutions":[{"id":"https://openalex.org/I4210090340","display_name":"Institut de Canc\u00e9rologie Strasbourg","ror":"https://ror.org/008fdbn61","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210090340"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Emmanuel Kurtz","raw_affiliation_strings":["Department of Medical and Surgical Oncology & Hematology, Institut de Canc\u00e9rologie Strasbourg Europe (ICANS), Strasbourg, France. Electronic address: je.kurtz@icans.eu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical and Surgical Oncology & Hematology, Institut de Canc\u00e9rologie Strasbourg Europe (ICANS), Strasbourg, France. Electronic address: je.kurtz@icans.eu","institution_ids":["https://openalex.org/I4210090340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109987327","display_name":"Francesco DEL PIANO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Francesco Del Piano","raw_affiliation_strings":["H\u00f4pitaux Du L\u00e9man, Thonon Les Bains, France. Electronic address: f-delpiano@ch-hopitauxduleman.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pitaux Du L\u00e9man, Thonon Les Bains, France. Electronic address: f-delpiano@ch-hopitauxduleman.fr","institution_ids":["https://openalex.org/I4210097159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074368454","display_name":"J\u00e9r\u00f4me Meunier","orcid":"https://orcid.org/0009-0008-6546-5470","observed_orcids":["https://orcid.org/0009-0008-6546-5470"]},"institutions":[{"id":"https://openalex.org/I4210144652","display_name":"Centre hospitalier universitaire d'Orl\u00e9ans","ror":"https://ror.org/04yvax419","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210144652"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"J\u00e9r\u00f4me Meunier","raw_affiliation_strings":["Medical Oncology Department, Centre Hospitalier R\u00e9gional, Orl\u00e9ans, France. Electronic address: jerome.meunier@chr-orleans.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Hospitalier R\u00e9gional, Orl\u00e9ans, France. Electronic address: jerome.meunier@chr-orleans.fr","institution_ids":["https://openalex.org/I4210144652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044300677","display_name":"Nadia Raban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Nadia Raban","raw_affiliation_strings":["H\u00f4pital de la Mil\u00e9trie, Poitiers, France. Electronic address: Nadia.RABAN@chu-poitiers.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital de la Mil\u00e9trie, Poitiers, France. Electronic address: Nadia.RABAN@chu-poitiers.fr","institution_ids":["https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091487792","display_name":"J\u00e9r\u00f4me Alexandre","orcid":"https://orcid.org/0000-0001-5252-5800","observed_orcids":["https://orcid.org/0000-0001-5252-5800"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"J\u00e9rome Alexandre","raw_affiliation_strings":["Universit\u00e9 de Paris, Institut du Cancer Paris CARPEM, AP-HP, APHP Centre, Department of Medical Oncology, Cochin-Port Royal, Paris, France. Electronic address: jerome.alexandre@cch.aphp.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Paris, Institut du Cancer Paris CARPEM, AP-HP, APHP Centre, Department of Medical Oncology, Cochin-Port Royal, Paris, France. Electronic address: jerome.alexandre@cch.aphp.fr","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210097159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069540694","display_name":"Marie\u2010Ange Mouret\u2010Reynier","orcid":"https://orcid.org/0000-0001-6981-1678","observed_orcids":["https://orcid.org/0000-0001-6981-1678","https://orcid.org/0000-0001-5542-5813"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]},{"id":"https://openalex.org/I4387155818","display_name":"Imagerie Mol\u00e9culaire et Strat\u00e9gies Th\u00e9ranostiques","ror":"https://ror.org/03y61y350","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I198244214","https://openalex.org/I4387155818"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Marie-Ange Mouret-Reynier","raw_affiliation_strings":["Centre Jean Perrin, Clermont-Ferrand, France. Electronic address: Marie-ange.mouret-reynier@clermont.unicancer.fr","IMoST - Imagerie Mol\u00e9culaire et Strat\u00e9gies Th\u00e9ranostiques (58, Rue Montalembert, 63005 Clermont-Ferrand - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Clermont-Ferrand, France. Electronic address: Marie-ange.mouret-reynier@clermont.unicancer.fr","institution_ids":["https://openalex.org/I4210124119"]},{"raw_affiliation_string":"IMoST - Imagerie Mol\u00e9culaire et Strat\u00e9gies Th\u00e9ranostiques (58, Rue Montalembert, 63005 Clermont-Ferrand - France)","institution_ids":["https://openalex.org/I4387155818"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073713547","display_name":"Isabelle Laure Ray-Coquard","orcid":"https://orcid.org/0000-0003-2472-8306","observed_orcids":["https://orcid.org/0000-0003-2472-8306","https://orcid.org/0000-0003-2857-3807"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I203339264","display_name":"Universit\u00e9 de Lyon","ror":"https://ror.org/01rk35k63","country_code":"FR","type":"education","lineage":["https://openalex.org/I203339264"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Isabelle Ray-Coquard","raw_affiliation_strings":["Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France. Electronic address: isabelle.ray-coquard@lyon.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 Claude Bernard Lyon 1, University of Lyon, Lyon, France. Electronic address: isabelle.ray-coquard@lyon.unicancer.fr","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I203339264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069960152","display_name":"Magali Provansal","orcid":"https://orcid.org/0009-0007-2820-7299","observed_orcids":["https://orcid.org/0009-0007-2820-7299"]},"institutions":[{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Magali Provansal Gross","raw_affiliation_strings":["Medical Oncology, Institute Paoli Calmettes, Marseille, France. Electronic address: PROVANSALM@ipc.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Institute Paoli Calmettes, Marseille, France. Electronic address: PROVANSALM@ipc.unicancer.fr","institution_ids":["https://openalex.org/I4210150365"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113852754","display_name":"Pierre-Emmanuel Brachet","orcid":"https://orcid.org/0000-0003-3303-2634","observed_orcids":["https://orcid.org/0000-0003-3303-2634"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]},{"id":"https://openalex.org/I98702875","display_name":"Universit\u00e9 de Caen Normandie","ror":"https://ror.org/051kpcy16","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210105918","https://openalex.org/I98702875"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Pierre-Emmanuel Brachet","raw_affiliation_strings":["Medical Oncology Department, Centre Fran\u00e7ois Baclesse, Anticipe Inserm U1086, Universit\u00e9 Caen Normandie, Caen, France. Electronic address: brape@baclesse.unicancer.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Fran\u00e7ois Baclesse, Anticipe Inserm U1086, Universit\u00e9 Caen Normandie, Caen, France. Electronic address: brape@baclesse.unicancer.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210121964","https://openalex.org/I98702875"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":29,"corresponding_author_ids":["https://openalex.org/A5012447228","https://openalex.org/A5021197091","https://openalex.org/A5021893779","https://openalex.org/A5031850292","https://openalex.org/A5034544552","https://openalex.org/A5040102390","https://openalex.org/A5040855511","https://openalex.org/A5042461515","https://openalex.org/A5044300677","https://openalex.org/A5049641705","https://openalex.org/A5057110201","https://openalex.org/A5069540694","https://openalex.org/A5069960152","https://openalex.org/A5072225627","https://openalex.org/A5073713547","https://openalex.org/A5073787373","https://openalex.org/A5074368454","https://openalex.org/A5079807284","https://openalex.org/A5084177861","https://openalex.org/A5086083902","https://openalex.org/A5086294065","https://openalex.org/A5091487792","https://openalex.org/A5091655083","https://openalex.org/A5091793463","https://openalex.org/A5108249703","https://openalex.org/A5109987327","https://openalex.org/A5113852754"],"corresponding_institution_ids":["https://openalex.org/I100532134","https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I204730241","https://openalex.org/I2801843802","https://openalex.org/I4210089315","https://openalex.org/I4210090340","https://openalex.org/I4210094685","https://openalex.org/I4210097159","https://openalex.org/I4210099203","https://openalex.org/I4210100596","https://openalex.org/I4210105738","https://openalex.org/I4210106090","https://openalex.org/I4210111187","https://openalex.org/I4210121964","https://openalex.org/I4210123491","https://openalex.org/I4210124119","https://openalex.org/I4210131356","https://openalex.org/I4210134409","https://openalex.org/I4210135187","https://openalex.org/I4210135503","https://openalex.org/I4210135640","https://openalex.org/I4210144652","https://openalex.org/I4210150365","https://openalex.org/I4387154388","https://openalex.org/I4387155818","https://openalex.org/I4405269973","https://openalex.org/I98702875"],"apc_list":{"value":4020,"currency":"USD","value_usd":4020},"apc_paid":null,"fwci":1.2409,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.80571287,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"166","issue":"3","first_page":"389","last_page":"396"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":1.0},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8920000195503235},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6600000262260437},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9415470361709595},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.8821857571601868},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.85919588804245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6461063623428345},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6240662336349487},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6101130247116089},{"id":"https://openalex.org/C2780356529","wikidata":"https://www.wikidata.org/wiki/Q279324","display_name":"Gastrointestinal perforation","level":3,"score":0.5460517406463623},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5387329459190369},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5144772529602051},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47738879919052124},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4755908250808716},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44338059425354004},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4185481369495392},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41665852069854736},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33818554878234863},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.13303735852241516},{"id":"https://openalex.org/C2780199535","wikidata":"https://www.wikidata.org/wiki/Q223102","display_name":"Peritonitis","level":2,"score":0.0876292884349823}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ygyno.2022.06.022","doi":"https://doi.org/10.1016/j.ygyno.2022.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},{"id":"pmid:35902297","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35902297","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:HAL:hal-03867958v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-03867958","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Gynecologic Oncology, 2022, 166 (3), pp.389-396. ⟨10.1016/j.ygyno.2022.06.022⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.ygyno.2022.06.022","doi":"https://doi.org/10.1016/j.ygyno.2022.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1947168884","https://openalex.org/W2012171803","https://openalex.org/W2113122060","https://openalex.org/W2130659669","https://openalex.org/W2133537644","https://openalex.org/W2135947389","https://openalex.org/W2150683293","https://openalex.org/W2168951652","https://openalex.org/W2170928115","https://openalex.org/W2171658624","https://openalex.org/W2586120609","https://openalex.org/W2605456582","https://openalex.org/W2771690491","https://openalex.org/W2772288154","https://openalex.org/W2787266690","https://openalex.org/W2906473874","https://openalex.org/W2947590658","https://openalex.org/W2994977341","https://openalex.org/W3016364201","https://openalex.org/W3119280060","https://openalex.org/W3128856576","https://openalex.org/W4206535779"],"related_works":["https://openalex.org/W3088417878","https://openalex.org/W2105106087","https://openalex.org/W2069342331","https://openalex.org/W2990048933","https://openalex.org/W2090459496","https://openalex.org/W3014433309","https://openalex.org/W7124525574","https://openalex.org/W164100026","https://openalex.org/W2907792199","https://openalex.org/W2366717010"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-07-26T00:00:00"}